Current Status and Future Forecast of Hypertension Drug Market involving Sales, Revenue, Growth Rate - Pfizer Inc., Lupin Limited, Novartis AG, Ranbaxy Laboratories limited, AstraZenca plc., Johnson & Johnson Ltd., Boehringer Ingelheim
Request Sample Pages for more Professional and Technical insights @
Hypertension Drug Market Size is observed to gain traction owing to various factors including rise in population count suffering from high blood pressure.
Blood pressure is further categorized into primary high blood pressure and secondary high blood pressure. Primary high blood pressure holds the largest market share owing to its increasing number of cases due to changing lifestyle and various genetic factors. Primary hypertension is majorly influenced by the factors such as; excess salt in the diet, excess body weight, excessive intake of alcohol, and active or passive smoking. However, secondary high blood pressure accounts for a smaller market share. Secondary high blood pressures causes are easily identified that include chronic kidney disease, endocrine disorder, excess use of birth controlling pills.
According to Centres for Disease Control and Prevention (CDC), high blood pressure or hypertension is the major cause of heart disease, and heart stroke in the U.S. Moreover, approximately 32% of adults have high blood pressure in the U.S. which accounts for the ratio of 1 in every 3 adults. Additionally, high blood pressure is becoming one of the leading causes of death in North America during recent past.
Key players in the Hypertension Drug Market are:
• Pfizer Inc.
• Lupin Limited
• Novartis AG
• Ranbaxy Laboratories limited
• AstraZenca plc.
• Johnson & Johnson Ltd.
• Boehringer Ingelheim
• Merck & Company
• Sanofi S.A.
• Sun Pharmaceuticals LLC
Hypertension Drug Market is primarily driven by the factors such as growing number of patients suffering from high blood pressures globally. Hypertension majorly causes cardiovascular diseases like heart stroke, and heart failure which cause higher number of deaths. As per 2013 WHO reports, approximately 45% of heart related deaths were due to hypertension. Moreover, the rising preference for the sedentary lifestyle in the developing countries is another factor contributing to the growth of hypertension cases.
For 'Queries' related to this research report, Make an Enquiry @
Increasing expiry of patented drug has created lucrative opportunities in the existing market. In addition, increasing number and availability of generic drugs shall also boost the growth of Hypertension Drug Market. Also, the rising interest of local governments and their increased focus on patient assistance to propel the global market.
Geographically, the market to be segmented as North America, Europe, Asia Pacific, Latin America & Middle East and Africa. Among the region, North America is expected to dominate this market during the forecast period. The North American region holds major share of this market owing to rising number of patients suffering from hypertension, and is one of the leading cause of death in this region. Also, increasing awareness for the use of alternative drugs, and increasing geriatric population in North America are factors enhancing the Hypertension Drug Market in the near future.
However, Asia Pacific is expected to witness fast market growth during the forecast period. Increasing number of patients with hypertension, and rising awareness for the use of various drugs and therapies are the major factor anticipated to govern the Hypertension Drug Market during upcoming years.
Table of Content of Hypertension Drug Market:
Chapter 1. Overview and Scope
Chapter 2. Market Summary
Chapter 3 Hypertension Drug Market Size and Forecast
Chapter 4. Dynamics and Segmentation
Chapter 5. Detailed Insight on Key Company
Chapter 6. Research Methodology and Reference
Chapter 7. Competitive Landscape
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.
Corporate Sales, USA
Polaris Market Research and Consulting
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Current Status and Future Forecast of Hypertension Drug Market involving Sales, Revenue, Growth Rate - Pfizer Inc., Lupin Limited, Novartis AG, Ranbaxy Laboratories limited, AstraZenca plc., Johnson & Johnson Ltd., Boehringer Ingelheim here
News-ID: 1351480 • Views: 94
More Releases from Polaris Market Research & Consulting
What's driving the Blockchain Technology Market Trends? Microsoft Corporation, I …
The worldwide market size for blockchain technology is estimated to grow at a CAGR of 41.6% between 2018 and 2026 and is anticipated to reach USD 16.82 billion by 2026. According to a new study published by Polaris Market Research. Also termed as Distributed Ledger Technology (DLT), blockchain enables secure transaction over a distributed network. Since the transactions are taken place usually over the network, it is difficult to reverse
What's driving the Precision Farming Market Trends? Ag Leader Technology, AgJunc …
The global precision farming/agriculture market was valued at 3,833 million in 2017 and is anticipated to reach over USD 13,016 million by 2026 with grow at a CAGR of more than 14.7% during the forecast period According to a new study published by Polaris Market Research. In 2017, the yield monitoring application dominated the global market, in terms of revenue. North America is expected to be the leading contributor to
What are the different trends in Electric Vehicles (EV) Market to boost its grow …
Polaris Market Research has new report published the addition of the “The global Electric Vehicles Market Worth $912 Billion By 2026 | CAGR: 38.4%”, the report classifies the global Electric Vehicles market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth Get PDF Sample of “Electric Vehicles Market”: https://www.polarismarketresearch.com/industry-analysis/electric-vehicles-ev-market/request-for-sample The global electric vehicles market is anticipated to
What are the different trends in Third Party Logistics Market to boost its growt …
Polaris Market Research has new report published the addition of the “The global third-party logistics market is anticipated to reach USD 1,337.91 billion by 2026”, the report classifies the global third-party logistics market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth according to a new report The report “Third Party Logistics (3PL) Market Share, Size,
More Releases for Hypertension
4th International Conference on Hypertension & Healthcare
We take the privilege of hosting International Hypertension meetings worldwide and very excited to expand to 4th International Conference on Hypertension & Healthcare to be held in beautiful city Zurich, Switzerland in the month of September 10th- 11th, 2018. As with the three meetings, the Hypertension 2018 will be on high-level updates, debates, hot topics and future research directions in the areas of Cardiology, cardiovascular diseases, Pulmonary Hypertension, Hypertension &
Global Pulmonary Arterial Hypertension Market to 2024
Global Pulmonary Arterial Hypertension (PAH) market was valued at $5.0bn in 2015 and is forecast to grow at a modest 6.0% CAGR between 2015 and 2024, to result in 2024 global sales of $9.0bn. PAH is broadly split into two classes, primary or secondary. Primary pulmonary hypertension (PPH) refers to pulmonary hypertension occurring without an identifiable cause. Secondary pulmonary arterial hypertension (PAH) occurs in association with some other identifiable medical condition.
Hypertension: Often unnoticed, always a risk
Vital mushrooms provide a valuable contribution in the prevention and therapy of hypertension Hypertension is considered one of the greatest health problems of the modern age. In the United Kingdom alone, according to data from the NHS, about 12,5 million people - almost every fourth - are affected. The great danger: Although hypertension can cause further serious diseases, many sufferers do not suspect their hypertension. They feel well and have
H2 2017 Pulmonary Arterial Hypertension - Pipeline Review
"The Report Pulmonary Arterial Hypertension - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Arterial Hypertension - Pipeline Review, H2 2017, provides an overview of the Pulmonary Arterial Hypertension (Cardiovascular) pipeline landscape. Pulmonary arterial hypertension (PAH) is a type of high blood pressure that occurs in the
Ocular Hypertension - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Ocular Hypertension - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Pipeline Review, H1 2017, provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous
Renal Hypertension: Diagnosis & Treatment
“Hypertension & Cardiovascular disease after Kidney Transplantation” is one of the workshops to be conducted by Dr. Hossein Tabriziani of Loma Linda University, USA under the session ‘Renal Hypertension’ at the meeting 2nd International Conference on Hypertension & Healthcare which is going to be held at Amsterdam, Netherlands during September 11-13, 2017. High blood pressure is a leading cause of kidney disease and kidney failure ESRD (end stage renal disease). Hypertension